Our law firm is now investigating cases involving bladder cancer as a result of taking Actos. A recent study suggests that when Actos is taken for longer periods of time, the risk of developing bladder cancer is increased. It appears that the longer Actos is taken, the greater the risk of developing bladder cancer. As a result, Actos has been removed from the market in France. In the United States, the FDA is updating the warning label.
|